rs397515963

Variant summary

Our verdict is Pathogenic. The variant received 20 ACMG points: 20P and 0B. PVS1PS3PP5_Very_Strong

The NM_000256.3(MYBPC3):​c.2373dupG​(p.Trp792ValfsTer41) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000269 in 1,563,840 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000299248: Functional studies demonstrate that this variant causes abberrant phosphorylation of contractile proteins, reduced maximal force-generating capacity of cardiomyocytes, and enhanced Ca2+ sensitivity (PMID:19273718 )." and additional evidence is available in ClinVar. Variant results in nonsense mediated mRNA decay. The gene MYBPC3 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000028 ( 0 hom. )

Consequence

MYBPC3
NM_000256.3 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:41O:1

Conservation

PhyloP100: 0.107

Publications

73 publications found
Variant links:
Genes affected
MYBPC3 (HGNC:7551): (myosin binding protein C3) MYBPC3 encodes the cardiac isoform of myosin-binding protein C. Myosin-binding protein C is a myosin-associated protein found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. MYBPC3 is expressed exclusively in heart muscle and is a key regulator of cardiac contraction. Mutations in this gene are a frequent cause of familial hypertrophic cardiomyopathy. [provided by RefSeq, May 2022]
MYBPC3 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 4
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • left ventricular noncompaction 10
    Inheritance: AD, AR Classification: DEFINITIVE, MODERATE, LIMITED Submitted by: Ambry Genetics
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • atrial fibrillation
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • congenital heart disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • dilated cardiomyopathy
    Inheritance: AR, AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 20 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PS3
PS3 evidence extracted from ClinVar submissions: SCV000299248: Functional studies demonstrate that this variant causes abberrant phosphorylation of contractile proteins, reduced maximal force-generating capacity of cardiomyocytes, and enhanced Ca2+ sensitivity (PMID: 19273718 ).; SCV001367637: PS3; SCV005398155: "This variant has moderate functional evidence supporting abnormal protein function. Mutant constructs expressed in mouse MYBPC3 KO engineered heart tissues displayed significantly different maximal force, contraction and relaxation kinetics, and external Ca2+ sensitivities compared with WT constructs. Moreover, mutant constructs were unable to rescue the MYBPC3 KO phenotype when expressed in either homozygous and heterozygous states." PMID:27108529; SCV005911682: Functional studies of this variant are supportive of a deleterious effect to the protein; however, it is unclear if this would be sufficient to be disease-causing (PMID:10736283).; SCV000917818: At least one publication reports experimental evidence evaluating an impact on protein function, demonstrating data that supports this variant causing loss-of-function (Van Dijk_2009).; SCV000059136: "In vitro functional studies support that this variant leads to a loss-of-function." PMID:10736283; SCV001572570: Functional studies demonstrated that the variant reduced maximal force-generating capacity of cardiomyocytes(PS3) (PMID: 19273718).; SCV004842354: A homozygous mouse model for this variant has shown a phenotype consistent with end-stage hypertrophic cardiomyopathy, severe cardiac hypertrophy, and cardiac dysfunction (PMID: 37844837).; SCV000208297: Published functional studies demonstrate c.2373dupG causes haploinsufficiency, deranged phosphorylation of contractile proteins, reduced maximal force-generating capacity of cardiomyocytes, and enhanced Ca2+ sensitivity (van Dijk et al., 2009); SCV003799249: Functional analyses of the variant protein show use of the cryptic splice site, leading to a frameshift and haploinsufficiency (Moolman 2000, van Dijk 2009). PMID: 10736283 PMID: 19273718; SCV000318483: Multiple functional studies have reported this mutation to result in loss of function (Moolman, 2000; van Dijk, 2009; Marston, 2012; Wijnker, 2016).; SCV001344628: A homozygous mouse model for this variant has shown a phenotype consistent with end-stage hypertrophic cardiomyopathy, severe cardiac hypertrophy, and cardiac dysfunction (PMID: 37844837).
PP5
Variant 11-47337729-A-AC is Pathogenic according to our data. Variant chr11-47337729-A-AC is described in ClinVar as Pathogenic. ClinVar VariationId is 42619.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000256.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYBPC3
NM_000256.3
MANE Select
c.2373dupGp.Trp792ValfsTer41
frameshift
Exon 24 of 35NP_000247.2Q14896-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYBPC3
ENST00000545968.6
TSL:5 MANE Select
c.2373dupGp.Trp792ValfsTer41
frameshift
Exon 24 of 35ENSP00000442795.1Q14896-1
MYBPC3
ENST00000399249.6
TSL:5
c.2373dupGp.Trp792ValfsTer41
frameshift
Exon 23 of 34ENSP00000382193.2A8MXZ9
MYBPC3
ENST00000544791.1
TSL:5
n.2373dupG
non_coding_transcript_exon
Exon 24 of 27ENSP00000444259.1F5GZR4

Frequencies

GnomAD3 genomes
AF:
0.0000198
AC:
3
AN:
151760
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000174
AC:
3
AN:
172018
AF XY:
0.0000109
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000428
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000276
AC:
39
AN:
1412080
Hom.:
0
Cov.:
33
AF XY:
0.0000301
AC XY:
21
AN XY:
697906
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32130
American (AMR)
AF:
0.00
AC:
0
AN:
37104
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25310
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36644
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80546
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49708
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5712
European-Non Finnish (NFE)
AF:
0.0000350
AC:
38
AN:
1086342
Other (OTH)
AF:
0.0000171
AC:
1
AN:
58584
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000198
AC:
3
AN:
151760
Hom.:
0
Cov.:
31
AF XY:
0.0000135
AC XY:
1
AN XY:
74092
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41284
American (AMR)
AF:
0.00
AC:
0
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5148
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4802
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10548
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
67954
Other (OTH)
AF:
0.00
AC:
0
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.608
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.000196
Hom.:
0
Bravo
AF:
0.0000453

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
14
-
-
Hypertrophic cardiomyopathy 4 (14)
12
-
-
not provided (12)
7
-
-
Hypertrophic cardiomyopathy (7)
2
-
-
Cardiomyopathy (2)
2
-
-
Cardiovascular phenotype (2)
2
-
-
Primary familial hypertrophic cardiomyopathy (2)
1
-
-
Hypertrophic cardiomyopathy 4;C3715165:Left ventricular noncompaction 10 (1)
1
-
-
MYBPC3-related disorder (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.11
Mutation Taster
=0/200
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.35
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.35
Position offset: 1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs397515963; hg19: chr11-47359280; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.